What TV doesn't, print can't; we deliver.
What TV doesn't, print can't; we deliver.
KOLKATA: Japan has approved the booster shot of Covaxin, the anti-Covid vaccine developed by India’s Bharat Biotech, for travellers, the drug maker announced on Friday. “We are proud to announce that Japan has approved COVAXIN booster dose for travellers. Another global recognition of the effectiveness of our universal COVID vaccine,” Bharat Biotech stated. Earlier in April, […]
NEW DELHI: India’s Bharat Biotech, Switzerland’s ExcellGene SA and University of Sydney have come together to manufacture a “variant-proof” Covid-19 vaccine. The SARS-CoV-2 vaccine candidate will be developed under the recently-approved consortium funding through the Coalition for Epidemic Preparedness Innovations (CEPI). Under this initiative, CEPI will provide funding up to USD 19.3 million for phase […]
NEW DELHI: Germany has decided to recognize WHO-listed Covaxin for travelling to Germany from June 1, German Ambassador to India Walter J Linder said on Thursday. The German Embassy in New Delhi has been pushing for this decision to Berlin for a long time as thousands of Indian travellers, inoculated by Covaxin, waited for the […]
NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday granted a restricted emergency use authorisation to Bharat Biotech’s Covaxin for children aged 6-12 years. Covaxin is one of the first COVID-19 vaccines in the world to generate data in the 2-18 year age group. The authorisation is given to Bharat Biotech after […]
